These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 15284314

  • 21. [Screening for cervical cancer in the county of Funen. Status of 25 years of development and experiences].
    Hølund B, Grinsted P.
    Ugeskr Laeger; 2006 May 29; 168(22):2163-6. PubMed ID: 16768956
    [Abstract] [Full Text] [Related]

  • 22. Endoscopic screening for gastric cancer.
    Dan YY, So JB, Yeoh KG.
    Clin Gastroenterol Hepatol; 2006 Jun 29; 4(6):709-16. PubMed ID: 16765306
    [Abstract] [Full Text] [Related]

  • 23. [Cost effectiveness of cervical cancer screening strategies in Tunisia].
    Hsaïri M, Fakhfakh R, Ghyoula M, Ben Abdallah M, Achour N.
    Tunis Med; 2000 Oct 29; 78(10):557-61. PubMed ID: 11190738
    [Abstract] [Full Text] [Related]

  • 24. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
    Plunkett BA, Grobman WA.
    Am J Obstet Gynecol; 2005 Apr 29; 192(4):1153-61. PubMed ID: 15846195
    [Abstract] [Full Text] [Related]

  • 25. Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.
    Thiry N, De Laet C, Hulstaert F, Neyt M, Huybrechts M, Cleemput I.
    Int J Technol Assess Health Care; 2009 Apr 29; 25(2):161-70. PubMed ID: 19366497
    [Abstract] [Full Text] [Related]

  • 26. Cost-effectiveness analysis of HPV vaccination alongside cervical cancer screening programme in Slovenia.
    Obradovic M, Mrhar A, Kos M.
    Eur J Public Health; 2010 Aug 29; 20(4):415-21. PubMed ID: 20624834
    [Abstract] [Full Text] [Related]

  • 27. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK, Ngan HY, Chu TY, Cheung AN, Tay EH.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [Abstract] [Full Text] [Related]

  • 28. [Cost effectiveness of human papilloma virus testing in cervical cancer screening: a literature review].
    Mejía A, Salas W.
    Biomedica; 2008 Mar 19; 28(1):160-72. PubMed ID: 18645671
    [Abstract] [Full Text] [Related]

  • 29. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM, Hunter MI, Sadeghi M, Edwards G, Bajamundi K, Monk BJ.
    J Low Genit Tract Dis; 2007 Oct 19; 11(4):258-64. PubMed ID: 17917570
    [Abstract] [Full Text] [Related]

  • 30. An alternative cost effectiveness analysis of ThinPrep in the Australian setting.
    Neville AM, Quinn MA.
    Aust N Z J Obstet Gynaecol; 2005 Aug 19; 45(4):289-94. PubMed ID: 16029294
    [Abstract] [Full Text] [Related]

  • 31. Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan.
    Maeda K, Shimbo T, Fukui T.
    J Med Screen; 2004 Aug 19; 11(2):97-102. PubMed ID: 15153326
    [Abstract] [Full Text] [Related]

  • 32. Organisation of cervical cytology screening in Croatia: past, present and future.
    Pajtler M, Audy-Jurković S, Kardum-Skelin I, Mahovlić V, Mozetic-Vrdoljak D, Ovanin-Rakić A.
    Coll Antropol; 2007 Apr 19; 31 Suppl 2():47-54. PubMed ID: 17598505
    [Abstract] [Full Text] [Related]

  • 33. Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France.
    Bergeron C, Largeron N, McAllister R, Mathevet P, Remy V.
    Int J Technol Assess Health Care; 2008 Apr 19; 24(1):10-9. PubMed ID: 18218164
    [Abstract] [Full Text] [Related]

  • 34. Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women.
    Kwon JS, Lu KH.
    Obstet Gynecol; 2008 Jul 19; 112(1):56-63. PubMed ID: 18591308
    [Abstract] [Full Text] [Related]

  • 35. ["Cost-effectiveness" of cervical screening].
    Kostova P.
    Akush Ginekol (Sofiia); 2007 Jul 19; 46(6):32-4. PubMed ID: 17974169
    [Abstract] [Full Text] [Related]

  • 36. [Costs and effects of alternative screening programs against cervical cancer].
    Gyrd-Hansen D, Hølund B, Andersen P.
    Ugeskr Laeger; 1996 Aug 26; 158(35):4912-5. PubMed ID: 8801698
    [Abstract] [Full Text] [Related]

  • 37. Cost effectiveness and cost utility of an organized screening programme for glaucoma.
    Vaahtoranta-Lehtonen H, Tuulonen A, Aronen P, Sintonen H, Suoranta L, Kovanen N, Linna M, Läärä E, Malmivaara A.
    Acta Ophthalmol Scand; 2007 Aug 26; 85(5):508-18. PubMed ID: 17655612
    [Abstract] [Full Text] [Related]

  • 38. The German cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in Germany.
    Siebert U, Sroczynski G, Hillemanns P, Engel J, Stabenow R, Stegmaier C, Voigt K, Gibis B, Hölzel D, Goldie SJ.
    Eur J Public Health; 2006 Apr 26; 16(2):185-92. PubMed ID: 16469759
    [Abstract] [Full Text] [Related]

  • 39. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
    Hassan C, Zullo A, Winn S, Morini S.
    Endoscopy; 2008 May 26; 40(5):414-21. PubMed ID: 18302080
    [Abstract] [Full Text] [Related]

  • 40. Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese.
    Xie F, Luo N, Blackhouse G, Goeree R, Lee HP.
    Int J Technol Assess Health Care; 2008 May 26; 24(1):87-95. PubMed ID: 18218173
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.